Notification of Transactions of Directors, Persons Discharging Managerial Responsibility or Connected Persons
I give below details of an increase in interests in Ordinary shares in GlaxoSmithKline plc purchased at a price of £12.43 per share on 10 January 2011, and Ordinary share ADRs in GlaxoSmithKline plc purchased at a price of $38.76 per ADR on 6 January 2011, in respect of the personal holdings of the under-mentioned persons following the re-investment of the dividend paid to shareholders on 6 January 2011.
|
Ordinary shares |
ADRs |
Dr M M Slaoui |
163.46 |
157.59 |
Kristen Belmonte |
5.76 |
|
Mr J M Clarke |
415.16 |
|
Mr M Dunoyer |
2.26 |
|
Mr E J Gray |
234.41 |
|
Mr W C Louv |
123.79 |
|
Mr D J Phelan |
302.52 |
|
Dr D Pulman |
186.18 |
|
Mr D S Redfern |
126.91 |
|
Mr J R Stéphenne |
614.30 |
|
Ms C Thomas |
96.07 |
|
Mr P J T Vallance |
57.46 |
|
The Company was advised of this information on 11 January 2011.
This notification relates to a transaction notified in accordance with Disclosure and Transparency Rule 3.1.4R(1)(a).
V A Whyte
Company Secretary
11 January 2011